LSK Global PSrecruits Dr. Dae-Hee Shin, expert of new drug

development, as itsnew Business & Science Vice President

- Dr. Shin known as the drugdevelopment expert for his successul compeletion of early clinical trials inthe US

- Will contribute tostrengthen and differentiate LSK Global PS’ clinical trials related consultingas well as professional new drug development fields

Korea’s leading contract research organization (CRO) LSK Global PS (LSKGlobal Pharma Services Co., Ltd.) announced the recruitment of Dr. Dae-Hee Shinas the new Business & Science Vice President as ofJune 1^st, 2017. This recruitment decision is based on LSKGlobal PS’ vision to support and become a stronger new drug development partnerto increasing number of Korean pharmaceutical companies expanding to the overseasmarket.

Vice President Shin is a graduate from the Department of Pharmacyat Sungkyunkwan University, School of Pharmacy and holds a Ph.D. in PharmaceuticalChemistry from Sungkyunkwan University, Graduate School of Medicine. He hasbeen recognized as one of the leading experts in related fields as the Chairmanof the Korean Association of Herbal Medicine Products under the Korean DrugResearch Association (KDRA). Prior to LSK Global PS, Dr. Shin worked at ChoSeonPharmaceutical & Trading as Director of Production Division and VicePresident of Life Science Research Institute, Director of Central ResearchInstitute at Daehwa Pharmaceutical, CEO at Chungbuk Technopack’s ChungbukOriental Medicine Center, Director at Huons, Director at Young-JinPharmaceutical’s R&D department and President at HLB Life Science’s Biodepartment. Among many achievements, Dr. Shin is the most recognized for hissuccessful pre-clinical, FIH initial phase 1 and 2A of COPD treatment in the USwhile serving as Director at Young-Jin Pharmaceutical’s R&D department.

Vice President Dae-Hee Shin, based on his experiences andknow-hows from drug development, various government projects, license relatedgovernment affairs tasks and overseas clinical trials, will provide moreefficient and effective consulting services to Korean pharmaceutical companiesso they can successfully create new drugs and expand overseas.

#  #  #